Wave aims for monthly dosing with RNA editing treatment for AATD

Wave Life Sciences reported an updated cut of data from its early-stage study of an RNA editing treatment for alpha-1 antitrypsin deficiency, suggesting that it can dose its genetic therapy monthly.

Raccontata daendpoints.news